首页> 外文期刊>Journal of commercial biotechnology >The Sarbanesa€“Oxley Act and non-US issuers: Considerations for international companies
【24h】

The Sarbanesa€“Oxley Act and non-US issuers: Considerations for international companies

机译:《萨班斯法案》和非美国发行人:对国际公司的考虑

获取原文
           

摘要

The Sarbanesa€“Oxley Act of 2002 was signed into law by President George W. Bush on 30th July, 2002, in the wake of an unprecedented wave of corporate governance and accounting scandals that fundamentally shook public confidence in the integrity of the US securities markets. The Act's widespread effects continue to be analysed and dissected by companies and their advisors both in the USA and abroad. One of the most controversial elements of this legislation is its impact outside the borders of the USA, which is beginning to affect some of the most basic corporate governance and disclosure practices of companies worldwide. Foreign issuers subject to the Act must now begin to review their corporate governance practices carefully in order to ensure compliance with the new rules.
机译:2002年7月30日,美国总统乔治·W·布什(George W. Bush)将2002年《萨班斯法案》(Sarbanesa'Oxley Act)签署为法律,这是前所未有的公司治理和会计丑闻浪潮,从根本上动摇了公众对美国证券市场完整性的信心。该法案的广泛影响将继续由美国和国外的公司及其顾问进行分析和剖析。该立法最具争议的要素之一是其在美国境外的影响,这一影响开始影响全球公司的一些最基本的公司治理和披露惯例。受该法案约束的外国发行人现在必须开始认真审查其公司治理实践,以确保遵守新规则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号